The humanoid robot industry now has a baseline: roughly 7,000 units sold globally in 2025, many of them parked in labs rather than doing productive work2. That figure lands in the same week Tesla is auditing Chinese suppliers for mass production, Dongfeng is preparing to send its first humanoid into a factory, and Unitree's stock has shed more than half its peak value. ANALYSIS Together, the data points sketch an industry caught between a credible but tiny installed base and production targets that assume orders-of-magnitude growth within months.
Why it matters
The International Federation of Robotics tally is the first authoritative attempt to count how many autonomous humanoids are actually in the field. ◆ It arrives at a moment when capital markets, automakers, and component suppliers are all pricing in a future measured in tens of thousands of units per year, making the gap between present reality and near-term ambition impossible to ignore.
The big picture
The IFR reported that approximately 7,000 autonomous humanoids were sold worldwide in 2025 for industrial and professional service use, with many purchased for research rather than productive deployment. Against that installed base, Tesla's robotics team last week launched a new round of supply chain audits across the Yangtze River Delta, covering Ningbo, Hangzhou, Shanghai, and other locations3,6. Multiple core suppliers, including Tuopu Group, Sanhua Intelligent Controls, and Joyson Electronics, have already received Tesla humanoid orders and will move into production once audits clear. Tesla aims to produce approximately 50,000 Optimus units in 2026 for deployment across its global factories. The third-generation Optimus is Tesla's first mass-production model, with a per-unit target cost of $20,000 to $30,000. Tesla's former Model S/X production line has been converted into a dedicated robot line with planned annual capacity of 1 million units.
Separately, Dongfeng Motor plans to send its Xiaodong humanoid robot into a factory in October for sorting and quality-inspection work, begin small-batch trial production by the end of 2026, and bring on-job capability in line with human workers by the end of 2027, according to Zhang Zhenlin, the automaker's chief engineer of intelligent technology1,5. Zhang argued that automakers' embodied-intelligence programs let technology reuse across automotive large models, speeding commercialization.
Meanwhile, the market's enthusiasm for humanoid pure-plays is cooling fast. Unitree Robotics opened at 1,100 yuan on its August 19 Shanghai STAR Market debut, briefly reaching a valuation of approximately $66 billion7. By early September, the stock had fallen more than 50% from that peak, erasing roughly $30 billion in 11 days4. Unitree raised around $900 million in the IPO, with Tencent, Alibaba, and DeepSeek among its backers. The company is profitable, unlike many competitors, but its sales have largely been one-off purchases by universities and research institutions. Chinese regulators had warned about a humanoid robot bubble months before the listing.
Between the lines
Tesla's audit priorities have shifted from technical validation to production cost assessment, aligning with its $20,000 target retail price. A source stated that the inspected companies "had already received orders related to Tesla humanoids prior to this inspection" and that "production will begin very soon after passing the inspections". Most of the target companies have previously supplied parts for Tesla electric vehicles. ANALYSIS That pattern means Tesla is grafting humanoid production onto an existing automotive supply chain rather than building one from scratch.
Dongfeng's approach follows a similar logic. The automaker is validating Xiaodong on material-sorting scenarios inside its own automotive manufacturing operations, positioning the humanoid as an extension of vehicle production rather than a standalone product line. Zhang's framing that "future embodied products will not be limited to humanoids" and that vehicles themselves can be embodied platforms treats the robot as one node in a broader intelligent-systems architecture.
Unitree's stock trajectory offers a counterpoint. The company produces humanoid and quadruped robots known for running, dancing, and performing martial arts, but the harder question, as one analysis noted, is "whether those robots are becoming useful workers rather than highly sophisticated conference entertainment". With the IFR reporting that many of the 7,000 humanoids sold in 2025 went to research buyers rather than production floors, that question applies industry-wide.
What's next
Dongfeng's Xiaodong is scheduled to enter a factory for training by the end of October, with trial production by year-end. Tesla's supplier audits are expected to clear imminently, with production to follow. Tesla aims to deploy approximately 50,000 Optimus units across its Gigafactories in 2026, with potential consumer market entry by late 2027. Unitree, now valued at roughly $30 billion after its pullback, trades as a real-time referendum on whether the market will wait for humanoids to graduate from demos to deployment. The IFR's 7,000-unit count is the number every production target will now be measured against.